From its inception, ACEGID has been actively pursuing cutting-edge research in the genomics of infectious diseases. Through our core research drive and our track-record of research excellence, we have accessed competitive funds for several projects. We are apt to respond to emerging infections towards limiting their effects on human population. Our research portfolio spans several disease priorities of the World Health Organization and have received an investment of over $100,000,000 (One Hundred Million US Dollars). Below are highlights of some of our past and ongoing research projects:
African Centre of Excellence for Genomics of Infectious Diseases (2013 – 2019)
The project aimed at establishing at Redeemer’s University, an African Centre of Excellence that is devoted to the genomics of infectious diseases. The World Bank funded the project with US$ 8 million. One of ACEGID’s mandates was to apply the knowledge of genomics to addressing issues of infectious diseases in Africa. ACEGID worked to develop a critical mass of well-trained African scientists who use genomics to address African health problems. ACEGID established Africa’s first postgraduate curriculum in genomics of infectious diseases in Nigeria.
Genomic Characterization of Acute Febrile Illness in West Africa (2013 – 2017)
With funding from the United States National Institutes of Health (NIH), this project uses genomics tools to identify pathogens that cause fevers in the West African region with the plan to acquire adequate knowledge of the landscape of pathogens in the region. This knowledge will be used to develop diagnostic tools that can detect the pathogens in a single reaction.
CEPI Lassa Fever Epidemiology Study in Nigeria
ACEGID is one of the members of the Nigeria Lassa Research Consortium, which comprises of eight academic, health, research and policy institutions in Nigeria, Germany and the United States. The epidemiology study, funded by Coalition for Epidemic Preparedness Innovations (CEPI), is being conducted as preparation for the trials of safe, effective and affordable vaccines for Lassa Fever. It involves collection of incidence data, improving case definitions and identifying useful clinical endpoints. ACEGID is responsible for capacity building and leading the project’s sequencing effort.
One Health and accelerating Vaccines for Ebola and Lassa (OVEL) (2018 – 2021)
The OVEL project is a collaboration between the University of Cambridge and ACEGID to enhance the development and testing of vaccines for Ebola and Lassa fevers. This is done by correlating the viral genome in the natural reservoir and in human hosts to have complete information about the variation and diversity of the virus. This knowledge will be used to develop a comprehensive vaccine for the preventions of the two diseases.
In partnership with the National Malaria Elimination Program, the World Health Organization, US President’s Malaria Initiative and other partners, ACEGID executes several projects on the surveillance and characterization of malaria pathogens in circulation within Nigeria. We are also responsible for the genomic evaluation of the efficacy of antimalarial drugs deployed to control malaria in the country.
Genomic Characterization and Surveillance of Microbial Threats in West Africa (2017 – 2022)
With funding from Human Heredity and Health in Africa (H3Africa) and the United States National Institute of Health, this US$5.8 Million collaborative research project between ACEGID and our long-term partners is working to identify and characterize viral pathogens in West Africa. This characterization will enhance pathogen surveillance efforts and the development of diagnostic tools, serum-based surveillance test kits and better understanding of the pathogen-host interaction for the diseases. At the core of H3Africa is training of the next generation of African researchers who are capable of conducting independent genomics research projects.
ACEGID’s partners for the project include Irrua Specialist Teaching Hospital, Irrua (Nigeria), Kenema Government Hospital, Kenema (Sierra Leone), Université Cheikh Anta Diop (Senegal), The Broad Institute, Harvard University and Tulane University (USA).
JWARG Surveillance, Detection, Risks and Consequences of Severe Infectious Disease in West Africa (2017-2022)
ACEGID is working in partnership with the Joint West Africa Research Group (JWARG), led by the Walter Reed Army Institute of Research. The JWARG project seeks to prepare for and prevent future infectious disease epidemics by establishing coordinated systems to rapidly detect and respond to a wide range of human pathogens at the earliest possible stages.
ACEGID is responsible for the research administration, study planning and preparation, protocol development, laboratory and study team preparation, patient enrolment, sample collection and laboratory testing, and institution of quality assurance procedures for clinical data, laboratory results and adherence to international regulations guiding research on human subjects.
ACE Impact (2020 – 2024)
Following outstanding successes recorded by the centre in the ACE II programme, ACEGID was positively reviewed by the World Bank’s ACE team, and our request for a renewal of the ACE project was granted. This birthed the ACE Impact project. Through ACE Impact, ACEGID is poised to scale up its trainings and outreach programmes for more impact by building the capacity of public health institutions in the West African countries in using cutting-edge scientific approaches to find solutions for infectious diseases diagnosis, managements, outbreak preparedness and response.
Under this project, we will enhance and expand our in-person genomics training such that our graduates can use the materials they access in the trainings to conduct courses in their home countries. We will also expand our postgraduate programs by developing two new programmes in bioinformatics with applications to infectious diseases, as well as develop a massive open online course on the genomics of infectious diseases.
Sentinel Audacious Project (2020 – 2025)
ACEGID is working with the Broad Institute and other partners to develop Sentinel, an early warning and response system that detects viral threats in real time, connect this information in real-time to public health institutes and empower frontline health care workers. Thus, allowing the global community to stop infectious diseases before they spread. The system is built on three pillars viz: Detect, Connect and Empower.